Published in J Virol on December 01, 1999
Hint, Fhit, and GalT: function, structure, evolution, and mechanism of three branches of the histidine triad superfamily of nucleotide hydrolases and transferases. Biochemistry (2002) 2.42
RotaC: a web-based tool for the complete genome classification of group A rotaviruses. BMC Microbiol (2009) 2.06
Rotavirus replication: plus-sense templates for double-stranded RNA synthesis are made in viroplasms. J Virol (2004) 1.96
Mammalian reovirus nonstructural protein microNS forms large inclusions and colocalizes with reovirus microtubule-associated protein micro2 in transfected cells. J Virol (2002) 1.71
Conventional and unconventional mechanisms for capping viral mRNA. Nat Rev Microbiol (2011) 1.61
Identification and characterization of the helix-destabilizing activity of rotavirus nonstructural protein NSP2. J Virol (2001) 1.31
Reovirus sigma NS and mu NS proteins form cytoplasmic inclusion structures in the absence of viral infection. J Virol (2003) 1.23
Rotavirus NSP5: mapping phosphorylation sites and kinase activation and viroplasm localization domains. J Virol (2002) 1.23
Effect of intragenic rearrangement and changes in the 3' consensus sequence on NSP1 expression and rotavirus replication. J Virol (2001) 1.21
Cryoelectron microscopy structures of rotavirus NSP2-NSP5 and NSP2-RNA complexes: implications for genome replication. J Virol (2006) 1.20
Interaction of rotavirus polymerase VP1 with nonstructural protein NSP5 is stronger than that with NSP2. J Virol (2006) 1.15
De novo synthesis of minus strand RNA by the rotavirus RNA polymerase in a cell-free system involves a novel mechanism of initiation. RNA (2000) 1.15
Assortment and packaging of the segmented rotavirus genome. Trends Microbiol (2010) 1.10
Reovirus protein sigmaNS binds in multiple copies to single-stranded RNA and shares properties with single-stranded DNA binding proteins. J Virol (2000) 1.08
RNA-binding protein RBMS3 is expressed in activated hepatic stellate cells and liver fibrosis and increases expression of transcription factor Prx1. J Mol Biol (2007) 1.07
Structure-function analysis of rotavirus NSP2 octamer by using a novel complementation system. J Virol (2006) 1.06
Rotavirus nonstructural protein NSP5 interacts with major core protein VP2. J Virol (2003) 1.05
Dual selection mechanisms drive efficient single-gene reverse genetics for rotavirus. Proc Natl Acad Sci U S A (2010) 1.03
RNA-binding activity of the rotavirus phosphoprotein NSP5 includes affinity for double-stranded RNA. J Virol (2002) 1.02
Rotavirus glycoprotein NSP4 is a modulator of viral transcription in the infected cell. J Virol (2005) 1.02
The battle between rotavirus and its host for control of the interferon signaling pathway. PLoS Pathog (2013) 1.00
Rotavirus non-structural proteins: structure and function. Curr Opin Virol (2012) 0.99
Analysis of a temperature-sensitive mutant rotavirus indicates that NSP2 octamers are the functional form of the protein. J Virol (2002) 0.99
Rice black-streaked dwarf virus P6 self-interacts to form punctate, viroplasm-like structures in the cytoplasm and recruits viroplasm-associated protein P9-1. Virol J (2011) 0.97
Histidine triad-like motif of the rotavirus NSP2 octamer mediates both RTPase and NTPase activities. J Mol Biol (2006) 0.97
Crystallographic analysis reveals octamerization of viroplasm matrix protein P9-1 of Rice black streaked dwarf virus. J Virol (2011) 0.95
Sequestration of free tubulin molecules by the viral protein NSP2 induces microtubule depolymerization during rotavirus infection. J Virol (2009) 0.93
Cell-line-induced mutation of the rotavirus genome alters expression of an IRF3-interacting protein. EMBO J (2004) 0.93
Crystallographic and biochemical analysis of rotavirus NSP2 with nucleotides reveals a nucleoside diphosphate kinase-like activity. J Virol (2007) 0.89
Crystallographic Analysis of Rotavirus NSP2-RNA Complex Reveals Specific Recognition of 5' GG Sequence for RTPase Activity. J Virol (2012) 0.86
Rotavirus viroplasm proteins interact with the cellular SUMOylation system: implications for viroplasm-like structure formation. J Virol (2012) 0.86
Further characterisation of rotavirus cores: Ss(+)RNAs can be packaged in vitro but packaging lacks sequence specificity. Virus Res (2013) 0.81
A cypovirus VP5 displays the RNA chaperone-like activity that destabilizes RNA helices and accelerates strand annealing. Nucleic Acids Res (2013) 0.81
A novel form of rotavirus NSP2 and phosphorylation-dependent NSP2-NSP5 interactions are associated with viroplasm assembly. J Virol (2013) 0.81
Rotavirus variant replicates efficiently although encoding an aberrant NSP3 that fails to induce nuclear localization of poly(A)-binding protein. J Gen Virol (2012) 0.81
Multimerization of hepatitis delta antigen is a critical determinant of RNA binding specificity. J Virol (2009) 0.80
Electron microscopic analysis of rotavirus assembly-replication intermediates. Virology (2015) 0.79
Non-structural protein NSP2 induces heterotypic antibody responses during primary rotavirus infection and reinfection in children. J Med Virol (2008) 0.77
An ATPase activity associated with the rotavirus phosphoprotein NSP5. Virology (2007) 0.76
Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (1970) 1528.65
Eukaryotic transient-expression system based on recombinant vaccinia virus that synthesizes bacteriophage T7 RNA polymerase. Proc Natl Acad Sci U S A (1986) 32.58
Three-dimensional structure of rotavirus. J Mol Biol (1988) 3.79
Ribonucleic acid polymerase activity associated with purified calf rotavirus. J Gen Virol (1977) 3.40
Ultrastructural localization of rotavirus antigens using colloidal gold. Virus Res (1984) 2.95
Reassortant rotaviruses as potential live rotavirus vaccine candidates. J Virol (1985) 2.95
Three-dimensional structure of rhesus rotavirus by cryoelectron microscopy and image reconstruction. J Cell Biol (1990) 2.83
Purification and characterization of bovine rotavirus cores. J Virol (1982) 2.43
Reovirus-coded polypeptides in infected cells: isolation of two native monomeric polypeptides with affinity for single-stranded and double-stranded RNA, respectively. Virology (1976) 2.42
Characterization of rotavirus replication intermediates: a model for the assembly of single-shelled particles. Virology (1989) 2.18
Two non-structural rotavirus proteins, NSP2 and NSP5, form viroplasm-like structures in vivo. J Gen Virol (1999) 1.84
Three-dimensional structural analysis of recombinant rotavirus-like particles with intact and amino-terminal-deleted VP2: implications for the architecture of the VP2 capsid layer. J Virol (1997) 1.81
Rotavirus RNA replication: single-stranded RNA extends from the replicase particle. J Gen Virol (1990) 1.58
Template-dependent, in vitro replication of rotavirus RNA. J Virol (1994) 1.54
Rotavirus RNA polymerase requires the core shell protein to synthesize the double-stranded RNA genome. J Virol (1997) 1.52
In vivo and in vitro phosphorylation of rotavirus NSP5 correlates with its localization in viroplasms. J Virol (1997) 1.50
Characterization and replicase activity of double-layered and single-layered rotavirus-like particles expressed from baculovirus recombinants. J Virol (1996) 1.49
Rotavirus VP1 alone specifically binds to the 3' end of viral mRNA, but the interaction is not sufficient to initiate minus-strand synthesis. J Virol (1996) 1.49
Rotavirus VP3 expressed in insect cells possesses guanylyltransferase activity. Virology (1992) 1.47
cis-Acting signals that promote genome replication in rotavirus mRNA. J Virol (1996) 1.45
Isolation and genetic characterization of temperature-sensitive mutants of simian rotavirus SA11. Virology (1982) 1.43
Rotavirus NS26 is modified by addition of single O-linked residues of N-acetylglucosamine. Virology (1991) 1.39
Rotavirus SA11 genome segment 11 protein is a nonstructural phosphoprotein. J Virol (1989) 1.37
Synthesis of simian rotavirus SA11 double-stranded RNA in a cell-free system. Virus Res (1986) 1.35
Characterization of rotavirus guanylyltransferase activity associated with polypeptide VP3. J Gen Virol (1991) 1.33
The rotavirus nonstructural protein, NS35, possesses RNA-binding activity in vitro and in vivo. Virology (1992) 1.31
The rotavirus RNA-binding protein NS35 (NSP2) forms 10S multimers and interacts with the viral RNA polymerase. Virology (1994) 1.30
Structure and protein composition of the rotavirus replicase particle. Virology (1988) 1.29
Rotavirus RNA replication: VP2, but not VP6, is necessary for viral replicase activity. J Virol (1990) 1.29
Rotavirus NSP5 phosphorylation is up-regulated by interaction with NSP2. J Gen Virol (1998) 1.26
Synthesis of bluetongue virus-encoded phosphoprotein and formation of inclusion bodies by recombinant baculovirus in insect cells: it binds the single-stranded RNA species. J Gen Virol (1990) 1.24
Serine protein kinase activity associated with rotavirus phosphoprotein NSP5. J Virol (1997) 1.22
Amino terminus of reovirus nonstructural protein sigma NS is important for ssRNA binding and nucleoprotein complex formation. Virology (1998) 1.21
Human viral gastroenteritis. Clin Microbiol Rev (1989) 1.21
Nucleotide and amino acid sequence analysis of the rotavirus nonstructural RNA-binding protein NS35. Virology (1993) 1.17
RNA-binding and capping activities of proteins in rotavirus open cores. J Virol (1999) 1.15
Characterization of subviral particles in cells infected with simian rotavirus SA11. Virology (1986) 1.15
Intracellular RNA synthesis directed by temperature-sensitive mutants of simian rotavirus SA11. Virology (1990) 1.13
Characterization of temperature-sensitive mutants of simian rotavirus SA11: protein synthesis and morphogenesis. J Virol (1984) 1.13
Recovery and characterization of a replicase complex in rotavirus-infected cells by using a monoclonal antibody against NSP2. J Virol (1996) 1.10
Double-stranded RNA bacteriophage phi 6 protein P4 is an unspecific nucleoside triphosphatase activated by calcium ions. J Virol (1995) 1.09
The multimeric nonstructural NS2 proteins of bluetongue virus, African horsesickness virus, and epizootic hemorrhagic disease virus differ in their single-stranded RNA-binding ability. Virology (1995) 0.98
Negative control of p53 by Sir2alpha promotes cell survival under stress. Cell (2001) 15.05
Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization. Nat Med (1999) 10.16
VEGF contributes to postnatal neovascularization by mobilizing bone marrow-derived endothelial progenitor cells. EMBO J (1999) 6.62
Nitric oxide synthase modulates angiogenesis in response to tissue ischemia. J Clin Invest (1998) 5.95
Stimulation of bone formation in vitro and in rodents by statins. Science (1999) 5.55
Deacetylation of p53 modulates its effect on cell growth and apoptosis. Nature (2000) 4.93
Environment and development. Earth system science for global sustainability: grand challenges. Science (2010) 3.92
Tie2 receptor ligands, angiopoietin-1 and angiopoietin-2, modulate VEGF-induced postnatal neovascularization. Circ Res (1998) 3.79
Age-dependent impairment of angiogenesis. Circulation (1999) 3.47
N protein alone satisfies the requirement for protein synthesis during RNA replication of vesicular stomatitis virus. J Virol (1984) 3.00
Synergistic interaction between hypergastrinemia and Helicobacter infection in a mouse model of gastric cancer. Gastroenterology (2000) 2.99
Rab11 is required for trans-golgi network-to-plasma membrane transport and a preferential target for GDP dissociation inhibitor. Mol Biol Cell (1998) 2.86
Rescue of diabetes-related impairment of angiogenesis by intramuscular gene therapy with adeno-VEGF. Am J Pathol (1999) 2.83
Direct intramuscular gene transfer of naked DNA encoding vascular endothelial growth factor augments collateral development and tissue perfusion. Circulation (1996) 2.79
Synergistic enhancement of nuclear receptor function by p160 coactivators and two coactivators with protein methyltransferase activities. J Biol Chem (2001) 2.74
Methylation of histone H3 by coactivator-associated arginine methyltransferase 1. Biochemistry (2001) 2.74
Reciprocal relation between VEGF and NO in the regulation of endothelial integrity. Nat Med (1997) 2.73
Roles of topoisomerases in maintaining steady-state DNA supercoiling in Escherichia coli. J Biol Chem (2000) 2.58
The Ski oncoprotein interacts with the Smad proteins to repress TGFbeta signaling. Genes Dev (1999) 2.52
Transcription elongation factor P-TEFb mediates Tat activation of HIV-1 transcription at multiple stages. EMBO J (1998) 2.45
Regulated secretion in platelets: identification of elements of the platelet exocytosis machinery. Blood (1997) 2.44
Induction of antitumor activity by immunization with fusions of dendritic and carcinoma cells. Nat Med (1997) 2.31
Selective inhibitors of the osteoblast proteasome stimulate bone formation in vivo and in vitro. J Clin Invest (2003) 2.30
Interaction of glycogen synthase kinase 3beta with the DF3/MUC1 carcinoma-associated antigen and beta-catenin. Mol Cell Biol (1998) 2.29
Vascular endothelial growth factor/vascular permeability factor enhances vascular permeability via nitric oxide and prostacyclin. Circulation (1998) 2.25
Characterization of rotavirus replication intermediates: a model for the assembly of single-shelled particles. Virology (1989) 2.18
The role of water stress in the inactivation of messenger RNA of germinating wheat embryos. Proc Natl Acad Sci U S A (1968) 2.15
X-ray spectra estimation using attenuation measurements from 25 kVp to 18 MV. Med Phys (1999) 2.11
Formulation and physical characterization of large porous particles for inhalation. Pharm Res (1999) 2.10
Efficient interaction of HIV-1 with purified dendritic cells via multiple chemokine coreceptors. J Exp Med (1996) 2.08
Regulation of phosphatidylinositol 3'-kinase by tyrosyl phosphoproteins. Full activation requires occupancy of both SH2 domains in the 85-kDa regulatory subunit. J Biol Chem (1995) 2.06
Three-dimensional visualization of the rotavirus hemagglutinin structure. Cell (1993) 1.95
Estrogen receptor activation function 1 works by binding p160 coactivator proteins. Mol Endocrinol (1998) 1.95
Funding Canada's health care system: a tax-based alternative to privatization. CMAJ (1998) 1.92
What determines patient satisfaction with surgery? A prospective cohort study of 4709 patients following total joint replacement. BMJ Open (2013) 1.88
Resetting the biological clock: mediation of nocturnal circadian shifts by glutamate and NO. Science (1994) 1.88
Protection against vaginal SIV transmission with microencapsulated vaccine. Science (1993) 1.86
Genetic diversity of Pierce's disease strains and other pathotypes of Xylella fastidiosa. Appl Environ Microbiol (2001) 1.85
MEPE has the properties of an osteoblastic phosphatonin and minhibin. Bone (2004) 1.79
Human P-glycoprotein exhibits reduced affinity for substrates during a catalytic transition state. Biochemistry (1998) 1.75
Workshop to identify critical windows of exposure for children's health: immune and respiratory systems work group summary. Environ Health Perspect (2000) 1.74
Helical nanofilament phases. Science (2009) 1.71
Functional analysis of the cytoplasmic tail of Moloney murine leukemia virus envelope protein. J Virol (1997) 1.70
Rapid phosphorylation of Ets-2 accompanies mitogen-activated protein kinase activation and the induction of heparin-binding epidermal growth factor gene expression by oncogenic Raf-1. Mol Cell Biol (1997) 1.69
Early ribosomal RNA transcription and appearance of cytoplasmic ribosomes during germination of the wheat embryo. Nat New Biol (1971) 1.68
Peptide deformylase in Staphylococcus aureus: resistance to inhibition is mediated by mutations in the formyltransferase gene. Antimicrob Agents Chemother (2000) 1.67
Pseudo-achondrogenesis with fractures. Clin Genet (1972) 1.66
Rotavirus nonstructural protein NSP2 self-assembles into octamers that undergo ligand-induced conformational changes. J Biol Chem (2000) 1.66
Risk factors for periprosthetic fractures of the hip: a survivorship analysis. Clin Orthop Relat Res (2008) 1.66
Prevention of thromboembolism after spinal cord injury using low-molecular-weight heparin. Ann Intern Med (1990) 1.66
Potentiated angiogenic effect of scatter factor/hepatocyte growth factor via induction of vascular endothelial growth factor: the case for paracrine amplification of angiogenesis. Circulation (1998) 1.65
Achondroplasia and thanatophoric dwarfism in the newborn. Clin Genet (1971) 1.65
Bacterial Peptide deformylase inhibitors: a new class of antibacterial agents. Curr Med Chem (2005) 1.65
Resolution of remodeling in eosinophilic esophagitis correlates with epithelial response to topical corticosteroids. Allergy (2009) 1.64
Detection of cell wall mannoprotein Mp1p in culture supernatants of Penicillium marneffei and in sera of penicilliosis patients. J Clin Microbiol (1999) 1.61
Negative regulation of the heat shock transcriptional response by HSBP1. Genes Dev (1998) 1.61
Prospective study of exposure to environmental tobacco smoke and dysmenorrhea. Environ Health Perspect (2000) 1.60
Requirement for a kinase-specific chaperone pathway in the production of a Cdk9/cyclin T1 heterodimer responsible for P-TEFb-mediated tat stimulation of HIV-1 transcription. J Biol Chem (2000) 1.59
Smad1 interacts with homeobox DNA-binding proteins in bone morphogenetic protein signaling. J Biol Chem (1999) 1.56
Advanced ovarian cancer: phase III randomized study of sequential cisplatin-topotecan and carboplatin-paclitaxel vs carboplatin-paclitaxel. J Natl Cancer Inst (2010) 1.55
Smad5 and DPC4 are key molecules in mediating BMP-2-induced osteoblastic differentiation of the pluripotent mesenchymal precursor cell line C2C12. J Biol Chem (1998) 1.54
Initiation of nucleolar assembly is independent of RNA polymerase I transcription. Mol Biol Cell (2000) 1.54
Selective transgene expression for detection and elimination of contaminating carcinoma cells in hematopoietic stem cell sources. J Clin Invest (1996) 1.52
Induction of cell cycle arrest and B cell terminal differentiation by CDK inhibitor p18(INK4c) and IL-6. Immunity (1997) 1.52
Genetic susceptibility to benzene and shortened gestation: evidence of gene-environment interaction. Am J Epidemiol (2000) 1.52
Rotavirus open cores catalyze 5'-capping and methylation of exogenous RNA: evidence that VP3 is a methyltransferase. Virology (1999) 1.51
Isolation of the gene encoding the Drosophila melanogaster homolog of the Saccharomyces cerevisiae GCN2 eIF-2alpha kinase. Genetics (1998) 1.51
Total knee replacement in morbidly obese patients. Results of a prospective, matched study. J Bone Joint Surg Br (2006) 1.49
Vasculitis and retinoids. Lancet (1989) 1.49
Interleukin-2 transcription is regulated in vivo at the level of coordinated binding of both constitutive and regulated factors. Mol Cell Biol (1994) 1.46
Malaria chemoprophylaxis among European tourists in tropical Africa: use, adverse reactions, and efficacy. Bull World Health Organ (1990) 1.45
Targeted gene silencing of TLR4 using liposomal nanoparticles for preventing liver ischemia reperfusion injury. Am J Transplant (2011) 1.43
15-LOX-1: a novel molecular target of nonsteroidal anti-inflammatory drug-induced apoptosis in colorectal cancer cells. J Natl Cancer Inst (2000) 1.43
Pituitary adenylate cyclase-activating peptide (PACAP) in the retinohypothalamic tract: a potential daytime regulator of the biological clock. J Neurosci (1997) 1.40
Paclitaxel, carboplatin, and hexamethyl-melamine (taxchex) as first-line therapy for ovarian cancer. Cancer J Sci Am (1999) 1.39
Anisotropy and corotation of galactic cosmic rays. Science (2006) 1.39
A neuronal ryanodine receptor mediates light-induced phase delays of the circadian clock. Nature (1998) 1.39
Comment on "Identification of monochloro-nonabromodiphenyl ethers in the air and soil samples from South China". Environ Sci Technol (2011) 1.38
Ureteric bud cells secrete multiple factors, including bFGF, which rescue renal progenitors from apoptosis. Am J Physiol (1997) 1.38
Vascular endothelial growth factor/vascular permeability factor (VEGF/VPF) in normal and atherosclerotic human arteries. Am J Pathol (1997) 1.37
Synthesis of simian rotavirus SA11 double-stranded RNA in a cell-free system. Virus Res (1986) 1.35
Extracellular hmgb1 functions as an innate immune-mediator implicated in murine cardiac allograft acute rejection. Am J Transplant (2007) 1.34
WHO-defined 'myelodysplastic syndrome with isolated del(5q)' in 88 consecutive patients: survival data, leukemic transformation rates and prevalence of JAK2, MPL and IDH mutations. Leukemia (2010) 1.34
MCF-7 breast cancer cells overexpressing transfected c-erbB-2 have an in vitro growth advantage in estrogen-depleted conditions and reduced estrogen-dependence and tamoxifen-sensitivity in vivo. Breast Cancer Res Treat (1995) 1.34
Human immunodeficiency virus type 1 nef quasispecies in pathological tissue. J Virol (1992) 1.33
Collagen integrin receptors regulate early osteoblast differentiation induced by BMP-2. J Bone Miner Res (1999) 1.33
Molecular cloning and characterization of LR3, a novel LDL receptor family protein with mitogenic activity. Biochem Biophys Res Commun (1998) 1.32
Isolation and characterization of two proteins from Moraxella catarrhalis that bear a common epitope. Infect Immun (1998) 1.32
15-Lipoxygenase-1 mediates nonsteroidal anti-inflammatory drug-induced apoptosis independently of cyclooxygenase-2 in colon cancer cells. Cancer Res (2000) 1.31
Identification and characterization of the helix-destabilizing activity of rotavirus nonstructural protein NSP2. J Virol (2001) 1.31
Does obesity influence the clinical outcome at five years following total knee replacement for osteoarthritis? J Bone Joint Surg Br (2006) 1.31
The rotavirus nonstructural protein, NS35, possesses RNA-binding activity in vitro and in vivo. Virology (1992) 1.31
VCP, the mammalian homolog of cdc48, is tyrosine phosphorylated in response to T cell antigen receptor activation. EMBO J (1992) 1.30
The rotavirus RNA-binding protein NS35 (NSP2) forms 10S multimers and interacts with the viral RNA polymerase. Virology (1994) 1.30
Reversal of tolerance to human MUC1 antigen in MUC1 transgenic mice immunized with fusions of dendritic and carcinoma cells. Proc Natl Acad Sci U S A (1998) 1.29
Reverse transcriptase adds nontemplated nucleotides to cDNAs during 5'-RACE and primer extension. Biotechniques (2001) 1.29
Rotavirus RNA replication: VP2, but not VP6, is necessary for viral replicase activity. J Virol (1990) 1.29
Cell-free synthesis and assembly of vesicular stomatitis virus nucleocapsids. J Virol (1983) 1.28
The effects of cytokines and growth factors on osteoblastic cells. Bone (1995) 1.28